EMEA-002121-PIP03-19-M01
Key facts
| Invented name |
Quviviq
|
| Active substance |
Daridorexant
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0116/2022
|
| PIP number |
EMEA-002121-PIP03-19-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of insomnia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Idorsia Pharmaceuticals Deutschland GmbH
Tel. +41 588440000 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|